CLIMATE CHANGE IMPACT ON URBAN STORMWATER SYSTEM AND USE OF GREEN INFRASTRUCTURE FOR ADAPTATION: AN INVESTIGATION ON TECHNOLOGY, POLICY, AND GOVERNANCE

The world is urbanizing at an unprecedented rate, and cities are dominantly and increasingly becoming hubs for agglomerations of human population and economic activities, as well as major sources of environmental problems. Accordingly, humanity′s pursuit of global sustainability is becoming increasingly reliant on urban sustainability. Unfortunately, the traditional approaches of urbanization and urban stormwater management are inappropriate from the sustainability standpoint. By removing vegetation and topsoil and creating impervious structures, urbanization destroys natural biodiversity and hydrological processes. As a result, urban societies are disconnected from nature and deprived of ecosystem services including flood control, fresh air, clean water, and natural beauty. Due to disrupted hydrology, an urban landscape transforms most rainwater into stormwater runoff which is conveyed off the site through a system of curb-gutter-pipe, called gray infrastructure. While gray infrastructure efficiently mitigates the problem of flash floods in urban areas, it results in multiple other adverse environmental consequences such as loss of freshwater from urban landscapes, transfer of pollutants to receiving waters, and an increased potential of downstream flooding. Green infrastructure (GI) is regarded as a sound alternative that manages stormwater by revitalizing the natural processes of soil, water, and vegetation, and restoring ecosystem structures and functions. Thus, the approach re–establishes the lost socio–ecological connectivity and regenerates ecosystem services. However, despite being inevitably important for urban sustainability, and despite being the object of unrelenting expert advocacy for more than two decades, the approach is yet to become a mainstream practice. To widely implement GI, cities need to address two critical challenges. First, urban stormwater managers and decision makers should be ensured that the approach can adequately and reliably manage stormwater. In the time when flooding problems are rising due to climate change, this concern has become more prominent. Second, if there exist any other barriers, they should be replaced with strategies that help expedite the use of GI. This multidisciplinary research dealt with these two challenges. The study consisted of two major parts. In the first part, a computer model was developed for a combined sewer system of St. Louis, a city in the US state of Missouri, using U.S. EPA SWMM. Simulations for historical (1971-2000) and future (2041-2070) 50-yr 3-hr rainfall scenarios were then run on the model with and without GI. The simulation results showed a significant impact of increased precipitation on the system, which was considerably reduced after adding select GI measures to the modeled system. The following 4 types of GI were used: bio–retention cell, permeable pavement, green roof, and rain barrel. In the second part, a survey of relevant policies and governance mechanisms of eleven U.S. cities was conducted to identify potential barriers to GI and determine strategies to address them. The study also included the assessment of relevant city, state, and federal policies and governance structures. A total of 29 barriers were identified, which were grouped into 5 categories. Most of the identified barriers stem from cognitive barriers and socio–institutional arrangements. A total of 33 policies, also grouped into 5 groups, were determined to address the barriers. The investigation on governance revealed that current governance is highly technocratic and centralized, and hence has less opportunity for public involvement. Therefore, it is inherently inappropriate for GI, which requires extensive public involvement. This dissertation proposes a two–tier governance model suitable for implementing GI

RETRACTED: Innovative Practices for the Promotion of Local/Indigenous Knowledge for Disaster Risk Reduction Management in Sudur Paschim Province, Nepal

The description of the Retraction: This article has been retracted. The Original article has previously been published elsewhere without disclosure to the editor, permission to republish, or justification (ie, redundant publication).We apologise for any inconvenience this retraction may have caused readers.Refers to :RETRACTED: Innovative Practices for the Promotion of Local/Indigenous Knowledge for Disaster Risk Reduction Management in Sudur Paschim Province, NepalKabi Prasad Pokhrel, Shambhu Prasad Khatiwada, Narayan Prasad Paudyal, Keshav Raj Dhakal, Chhabi Lal Chidi, Narayan Prasad Timilsena, Dhana Krishna MahatJournal of Geographical Research, Volume 4, Issue 3, July 2021DOI of original article: https://doi.org/10.30564/jgr.v4i3.322

Global lessons from successful rhinoceros conservation in Nepal

Global populations of rhinoceros have declined alarmingly, from about 500,000 at the beginning of the 20th century to 29,000 in 2016, largely due to an escalation of poaching for rhinoceros horn (Traffic 2016; Biggs et al. 2013). The current global rhino population is comprised of three Asian Species and two African species, the latter located in South Africa, Kenya, Tanzania, Namibia and Zimbabwe,. In Africa, the Southern white rhinoceros population is estimated at 20,700; and there are estimated to be around 4,885 black rhinoceros. The greater one-horned rhinoceros, found in Nepal and India, has a population of approximately 3,555. The other Asian rhino species are confined to Indonesia and have much lower numbers; there are fewer than 100 Sumatran rhinos and only 58–61 Javan rhinos. The number of African rhino killed by poachers in the last ten years is estimated at 5,957 (Traffic 2016; Emslie et al. 2013; Poaching fact2016), about 1,338 of these were taken in 2015, a year in which the highest number of rhino were taken since the late 1980s (Traffic 2016; Gaworecki 2016; Figure 1). At current poaching rates, Africa’s rhino populations may be extinct within 20 years (Di Minin et al. 2015). The Sumatran and Javan rhino populations continue to decline due to habitat destruction, poaching and inbreeding (Save the Rhino, 2016b) pushing them to the verge of extinction

Zinc and provitamin A biofortified maize genotypes exhibited potent to reduce hidden-hunger in Nepal

Zinc deficiency affects one third of the population worldwide, and vitamin A deficiency is a prevalent public health issue in Sub-Saharan Africa and South-Asia, including Nepal. Crop biofortification is the sustainable solution to these health—related problems, thus we conducted two different field trials in an alpha lattice design to identify zinc and provitamin A biofortified maize genotypes consistent and competitive in performance over the contrasting seasons (Season 1: 18 February to 6 July 2020 and Season 2: 31 August to 1 February, 2020/21). In our study, the performance of introduced maize genotypes (zinc—15 and provitamin A biofortified—24) were compared with that of the local check, focusing on the overall agro-morphology, yield attributes, yield, and kernel zinc and total carotenoid content. Zinc and total carotenoid in the tested genotypes were found in the range between 14.2 and 24.8 mg kg−1 and between 1.8 and 3.6 mg 100 g−1. Genotypes A1831-8 from zinc and EEPVAH-46 from provitamin A biofortified maize trial recorded kernel zinc and total carotenoid as high as 52.3, and 79.5%, respectively, compared to the local check (DMH849). The provitamin A genotypes EEPVAH-46 and EEPVAH-51 (total carotenoid: 3.6 and 3.3 mg 100 g−1), and zinc biofortified genotypes A1847-10 and A1803-42 (20.4 and 22.4 mg kg−1 zinc) were identified as superior genotypes based on their yield consistency over the environments and higher provitamin A and zinc content compared to the check. In addition, farmers can explore August sowing to harvest green cobs during December-January to boost up the emerging green cob business

Predicting the potential distribution and habitat variables associated with pangolins in Nepal

Pangolins are highly-threatened due to illegal hunting and poaching, and by the loss, degradation, and fragmentation of their habitats. In Nepal, effective conservation actions for pangolins are scarce due to limited information on the distribution of pangolins in many areas of the country. To identify the nationwide distribution of pangolins in Nepal, and assess the environmental variables associated with their habitat, we conducted an extensive literature review to collate data from previous studies, canvassed information from key informant interviews and expert opinion, and conducted transect surveys and sign surveys. The occurrence of pangolins was recorded based on sightings and indirect signs (such as burrows, digs, tracks, and scats) along 115 belt transects of 500-m length with a fixed width of 50-m, and habitat parameters were surveyed using 347 quadrats of 10 m*10 m. Pangolin presence was confirmed from 61 out of 75 districts from the eastern to the far western parts of the country. The highest frequency of burrows (74%) was observed in the forested habitat constituting brown soil with medium texture (0.02–2 mm) within an elevation range of 500–1500 m above sea level. Logistic regression suggested that the occurrence of pangolin was highly influenced by ground cover and canopy cover of 50–75%, litter depth, and the distance to termite mounds and roads. We used 4136 occurrence GPS points of pangolin burrows that were compiled and collected from the literature review and field surveys in order to predict the potential habitat distribution of pangolin using maximum entropy algorithm (MaxEnt 3.4.1). The model predicted 15.2% (22,393 km2) of the total land of Nepal as potentially suitable habitat for pangolin, with 38.3% (8574 km2) of potential habitat in the eastern region, followed by 37.6% (8432 km2) in the central and 24.1% (5,387 km2) in the western regions. The results of this study present a national baseline for pangolin distribution and serve as an important document for developing and executing conservation actions and management plans for the long-term conservation of pangolins in Nepal

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

Background Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy. Brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases (such as cerebral microbleeds) are associated with greater risks of recurrent intracerebral haemorrhage. We did subgroup analyses of the RESTART trial to explore whether these brain imaging features modify the effects of antiplatelet therapy

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

Background: Antiplatelet therapy reduces the risk of major vascular events for people with occlusive vascular disease, although it might increase the risk of intracranial haemorrhage. Patients surviving the commonest subtype of intracranial haemorrhage, intracerebral haemorrhage, are at risk of both haemorrhagic and occlusive vascular events, but whether antiplatelet therapy can be used safely is unclear. We aimed to estimate the relative and absolute effects of antiplatelet therapy on recurrent intracerebral haemorrhage and whether this risk might exceed any reduction of occlusive vascular events. Methods: The REstart or STop Antithrombotics Randomised Trial (RESTART) was a prospective, randomised, open-label, blinded endpoint, parallel-group trial at 122 hospitals in the UK. We recruited adults (≥18 years) who were taking antithrombotic (antiplatelet or anticoagulant) therapy for the prevention of occlusive vascular disease when they developed intracerebral haemorrhage, discontinued antithrombotic therapy, and survived for 24 h. Computerised randomisation incorporating minimisation allocated participants (1:1) to start or avoid antiplatelet therapy. We followed participants for the primary outcome (recurrent symptomatic intracerebral haemorrhage) for up to 5 years. We analysed data from all randomised participants using Cox proportional hazards regression, adjusted for minimisation covariates. This trial is registered with ISRCTN (number ISRCTN71907627). Findings: Between May 22, 2013, and May 31, 2018, 537 participants were recruited a median of 76 days (IQR 29–146) after intracerebral haemorrhage onset: 268 were assigned to start and 269 (one withdrew) to avoid antiplatelet therapy. Participants were followed for a median of 2·0 years (IQR [1·0– 3·0]; completeness 99·3%). 12 (4%) of 268 participants allocated to antiplatelet therapy had recurrence of intracerebral haemorrhage compared with 23 (9%) of 268 participants allocated to avoid antiplatelet therapy (adjusted hazard ratio 0·51 [95% CI 0·25–1·03]; p=0·060). 18 (7%) participants allocated to antiplatelet therapy experienced major haemorrhagic events compared with 25 (9%) participants allocated to avoid antiplatelet therapy (0·71 [0·39–1·30]; p=0·27), and 39 [15%] participants allocated to antiplatelet therapy had major occlusive vascular events compared with 38 [14%] allocated to avoid antiplatelet therapy (1·02 [0·65–1·60]; p=0·92). Interpretation: These results exclude all but a very modest increase in the risk of recurrent intracerebral haemorrhage with antiplatelet therapy for patients on antithrombotic therapy for the prevention of occlusive vascular disease when they developed intracerebral haemorrhage. The risk of recurrent intracerebral haemorrhage is probably too small to exceed the established benefits of antiplatelet therapy for secondary prevention

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

Background: Antiplatelet therapy reduces the risk of major vascular events for people with occlusive vascular disease, although it might increase the risk of intracranial haemorrhage. Patients surviving the commonest subtype of intracranial haemorrhage, intracerebral haemorrhage, are at risk of both haemorrhagic and occlusive vascular events, but whether antiplatelet therapy can be used safely is unclear. We aimed to estimate the relative and absolute effects of antiplatelet therapy on recurrent intracerebral haemorrhage and whether this risk might exceed any reduction of occlusive vascular events. Methods: The REstart or STop Antithrombotics Randomised Trial (RESTART) was a prospective, randomised, open-label, blinded endpoint, parallel-group trial at 122 hospitals in the UK. We recruited adults (≥18 years) who were taking antithrombotic (antiplatelet or anticoagulant) therapy for the prevention of occlusive vascular disease when they developed intracerebral haemorrhage, discontinued antithrombotic therapy, and survived for 24 h. Computerised randomisation incorporating minimisation allocated participants (1:1) to start or avoid antiplatelet therapy. We followed participants for the primary outcome (recurrent symptomatic intracerebral haemorrhage) for up to 5 years. We analysed data from all randomised participants using Cox proportional hazards regression, adjusted for minimisation covariates. This trial is registered with ISRCTN (number ISRCTN71907627). Findings: Between May 22, 2013, and May 31, 2018, 537 participants were recruited a median of 76 days (IQR 29–146) after intracerebral haemorrhage onset: 268 were assigned to start and 269 (one withdrew) to avoid antiplatelet therapy. Participants were followed for a median of 2·0 years (IQR [1·0– 3·0]; completeness 99·3%). 12 (4%) of 268 participants allocated to antiplatelet therapy had recurrence of intracerebral haemorrhage compared with 23 (9%) of 268 participants allocated to avoid antiplatelet therapy (adjusted hazard ratio 0·51 [95% CI 0·25–1·03]; p=0·060). 18 (7%) participants allocated to antiplatelet therapy experienced major haemorrhagic events compared with 25 (9%) participants allocated to avoid antiplatelet therapy (0·71 [0·39–1·30]; p=0·27), and 39 [15%] participants allocated to antiplatelet therapy had major occlusive vascular events compared with 38 [14%] allocated to avoid antiplatelet therapy (1·02 [0·65–1·60]; p=0·92). Interpretation: These results exclude all but a very modest increase in the risk of recurrent intracerebral haemorrhage with antiplatelet therapy for patients on antithrombotic therapy for the prevention of occlusive vascular disease when they developed intracerebral haemorrhage. The risk of recurrent intracerebral haemorrhage is probably too small to exceed the established benefits of antiplatelet therapy for secondary prevention